How Technology is Tackling the World's Greatest Healthcare Challenges in the Era of Personalized Medicine, at the Digital Health Summit at CES 2017

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to How Technology is Tackling the World's Greatest Healthcare Challenges in the Era of Personalized Medicine, at the Digital Health Summit at CES 2017

Jefferies Cuts Price Target on ResMed (RMD) to $56 Following 1Q Miss

October 26, 2016 7:11 AM EDT

Jefferies maintained an Underperform rating on ResMed (NYSE: RMD), and cut the price target to $56.00 (from $58.00), following the company's 1Q earnings report. ResMed reported a $10mn revenue miss on a $0.02 EPS miss. Organic growth of 3% drove EPS growth of 7%; however, excluding... More